Lactobacillus gasseri KML39
Lactobacillus gasseri KML39 has a single published study in the current indexed record: a 2025 animal model investigation in which fermented casein containing this strain was examined in a chemically induced colitis mouse model, in relation to systemic inflammation and gut-brain-microbiome axis interactions. This is an early-stage preclinical finding that has not been replicated or tested in human trials. L. gasseri as a species has a broader evidence base across other designated strains, but those findings cannot be applied to KML39 without dedicated research. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 1 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
1 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 40752622 →Fermented casein with Lactobacillus gasseri KML39 alleviates systemic inflammation interacting with the gut-brain-microbiome axis in dextran sulfate sodium–induced colitis mice· Journal of Dairy Science · 2025